Mahmoud Shelbaia

Senior Director Rare Diseases , Africa and Middle East at NewBridge Pharmaceuticals
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
United Arab Emirates, AE
Languages
  • Arabic -
  • English -
  • French -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Hany Philips

Mahmoud is a lovely person to work with, he is committed to what he does in a passion way and always seek improvement to excellence, I had the privilege to work with Mahmoud and pretty sure that, he will be driving business of vaccines, transplant at Pfizer

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Professional Diploma of Marketing CIM
    CIM

Experience

    • United Arab Emirates
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Senior Director Rare Diseases , Africa and Middle East
      • Dec 2021 - Present

    • Senior Director Market Access at NewBridge Pharmaceuticals
      • Mar 2021 - Nov 2021

      Joined Newbridge to develop & build the foundation of Access team platform & Rare Diseases Business where I managed both Access , sales & Marketing for whole Gulf, Saudi Arabia, north Africa & Pakistan Leading & partnering with internal stakeholders and optimizing the internal resources to create a collaborative expanded network that bring value to patients & community Leading the conversation to positively influence the external environment and leading the conversation with key stakeholders to strengthen New bridge Position, reputation and purpose Managing Iraq total portfolio , maximizing potential of current core portfolio and adopt wining strategies for new assets to get access and support more patients . Show less

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Pfizer Senior Director Commercial, Market Access, Public Affairs & Governmental relations
      • Jan 2019 - Mar 2021

      The role included Commercial Vaccines, Corporate Affairs & Market Access The below attributes contributed significantly to my success in the role. Leadership: managed Functions with 7 Senior Managers as direct report attracting the right talents from inside & outside the organization, developing and inspiring them to bring their best potential.Commercial Excellence: Setting access strategy to Pfizer COVID-19 Vaccines and leading the governmental interactions and master the head of term agreement process, develop the COVID-19 Vaccines, meningococcal and pneumococcal vaccines strategies to protect current national immunization project and win new NIPs (First 3 COVID-19 vaccines contracts in Lebanon, Jordan & Iraq Won two new tenders in Egypt and Jordan for meningococcal vaccines and protect and grow the current Pneumococcal NIPs)Lifecycle Management: Managing the core portfolio with different product lifecycle stages and optimize pricing to ensure the sustainability on the other hand managing the pipeline and asset planning with a launch excellence mindset. Affordability Solutions & Microfinancingleads affordability efforts across ELI with scalable programs and diversified solutions and ensure OPERA operational excellence & efficiency successful affordability projects such as Lebanon KERMALAK & Egypt with you for hope for Oncology products in Egypt presidential initiatives.Evidence (Unmet needs, RWE, Value creation) Evaluated the lifetime return on investment from use of the vaccines with Pfizer Global Access team& Harvard university (publishing a white paper) Led the team to generate budget impact models for new assets, Created E-MAX project as one of the best practices in EM & Reinforce the talk value project Show less

    • Senior Director Oncology & Vaccines Businesses
      • Aug 2016 - Dec 2018

      Managing both Oncology &Vaccines Businesses in ELI Cluster in which the following milestones have been achieved: Developed winning strategies and Leveraged strategic relationships with key internal and external influencers · Champions a metrics-based culture that considers metrics early and integrates them into planning and execution, that helped in vaccination & Cancer awareness · Works with internal stakeholders to enable execution of key marketing objectives and tactics; pushes boundaries; anticipates future rules in the marketplace (including compliance with legal and regulatory requirements) · Managing an organization of 44 people and 7 Direct reports. · Total 2018 Revenues are 65M$, IBA 41M$ & 26% Growth Show less

    • Vaccines Cluster Head
      • Jan 2014 - Jul 2016

      P/L Responsibility over a cluster of 71M$ total revenues & 46M$ IBA · Managing both Commercial & Marketing functions for Vaccines Business unit in 14 Markets within Pfizer AFME cluster.Maximize the profitability through optimized resources allocation to target growth opportunities. Built a sustainable foundation for Iraq Vaccines and participate in many projects to increase the awareness and vaccines compliance. Create a strong culture built on straight talk & transparency that helped in successful engagement of Gulf, Levant & Egypt team members as reflected on outstanding results of Pfizer Voice for the three consecutive years (2014, 2015& 2016)Clear the Way for Pfizer Vaccines Gulf, Levant & Egypt team by; Encouraging Innovation (Inspire project) & Dare to be different, Creating Enablers, Modeling the right behaviors, Articulating Ambition, Removing Barriers, Accelerating Action, and Linking Failure to Learning. Show less

    • Business Unit Director UAE,Oman, Qatar, Bahrain, Kuwait, Iraq, Iran, Egypt/Sudan, Lebanon& Jordan
      • Apr 2010 - Dec 2013

      • Managed both Sales & Marketing for Rare diseases &Vaccines portfolios in 11 countries.• Developed local strategies/action plans for supporting patients and enhance the access to Pfizer medications.• Access Improvement to Hemophilia Patients by Intensify partnership with World Federation of Hemophilia especially in Iraq, Support hemophilia treatment guidelines and develop patients support groups. (Lead the team to win two Xyntha consecutive tenders in Iraq ($30M -2012 & $14M-2013.)• Embraced the OWNIT culture, and established a healthy environment that cultivates success and brings out the best in People.• Total 2013 Revenues is $75M -$49M, IBA -38%G Show less

    • National Sales Manager Bahrain ( Country manager role with Wyeth before acquisition )
      • Feb 2008 - Mar 2010

      Managed P/L for total revenues of $10M including Ant invectives , CNS , Biological , transplant ,Vaccines & Nutrition Shaping the environment, launching new assets and maximize potential to generate new business and ensure sustainability. Worked towards maximizing customer engagement, and leading projects to further strengthen Pfizer’s credibility and relationship with various customer segments.High track record of team engagement enhancement plans.

    • Sales Manager ( Wyeth)
      • Jan 2004 - Jan 2008

      Managed Wyeth Portfolio including Anti-infective , Vaccines , Biologics ,CNS, Oncology, Hemophilia ,Female Health care &Nutritional Business .

    • Medical Sales Representative (Wyeth )
      • Jan 1999 - Jan 2004

    • Medical Sales Representative Wyeth
      • Jul 1996 - Dec 1998

Education

  • Mansoura University
    Good, BSC Pharmacy
    1991 - 1996
  • Chartered Management Institute
    Professional Diplomat of Marketing, Business, Management, Marketing, and Related Support Services
  • Mansoura University
    Bachelor of Applied Science - BASc

Community

You need to have a working account to view this content. Click here to join now